Bayer and Medsintez form alliance to develop, produce drugs

Bayer announced today that its HealthCare business and Russian drug manufacturer Medsintez (Moscow) have entered into a partnership to jointly manufacture and commercialize diagnostic imaging products as well as pharmaceuticals to treat infections and neural disorders. In addition, the companies intend to cooperate in R&D and production of new substances and medicines, aiming to accelerate the access to innovative pharmaceuticals for Russian patients. Joint marketing activities are scheduled to start in 2013. Bayer HealthCare and Medsintez will start their...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers